| | | Single nucleotide variant (missense variant) | CACNB4-related disorder | |
| | | Single nucleotide variant (synonymous variant) | Juvenile myoclonic epilepsy +5 more | |
| | | Single nucleotide variant (synonymous variant +1 more) | CACNB4-related disorder +2 more | |
| | | Single nucleotide variant (synonymous variant +1 more) | Idiopathic generalized epilepsy +2 more | |
| | | Single nucleotide variant (synonymous variant +1 more) | not provided +3 more | |
| | | Single nucleotide variant (missense variant +1 more) | CACNB4-related disorder +2 more | |
| | | Single nucleotide variant (intron variant) | CACNB4-related disorder | |
| | | Single nucleotide variant (missense variant +1 more) | Episodic ataxia type 5 +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (intron variant) | CACNB4-related disorder | |
| | | Single nucleotide variant (missense variant) | CACNB4-related disorder +4 more | |
| | | Single nucleotide variant (intron variant) | CACNB4-related disorder | |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | not provided +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant) | not specified +3 more | |
| | LOC129934925, CACNB4 (P15R) | Single nucleotide variant (missense variant) | Episodic ataxia type 5 +6 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant) | not provided +2 more | GConflicting classifications of pathogenicity |
| | CACNB4, LOC129934925 (S2F) | Single nucleotide variant (missense variant) | Epilepsy, idiopathic generalized, susceptibility to, 9 +6 more | GConflicting classifications of pathogenicity |